Opus Genetics (IRD) Other Accumulated Expenses (2019 - 2025)
Opus Genetics' (IRD) quarterly Other Accumulated Expenses came in at $268000.0 in Q3 2025, up 325.4% year-on-year from $63000.0 in Q3 2024, and up 1.13% on a QoQ basis from $265000.0 in Q2 2025.
Opus Genetics (IRD) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Opus Genetics (IRD) has 7 years of Other Accumulated Expenses data on file, last reported at $268000.0 in Q3 2025.
- On a quarterly basis, Other Accumulated Expenses rose 325.4% year-over-year to $268000.0 in Q3 2025; TTM through Sep 2025 was $268000.0, a 325.4% increase from a year earlier, with the FY2024 full-year figure at $606000.0, up 753.52% from the prior year.
- Other Accumulated Expenses for Q3 2025 stood at $268000.0, up from $265000.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for IRD reached as high as $606000.0 in Q4 2024 and fell as low as $8000.0 in Q3 2021.
- Historically, Other Accumulated Expenses has averaged $129789.5 across 5 years, with a median of $74000.0 in 2022.
- Across the five-year window, Other Accumulated Expenses soared 825.0% in 2022 and plunged 57.49% in 2023, its largest moves.
- Year by year, Other Accumulated Expenses stood at $80000.0 in 2021, then jumped by 108.75% to $167000.0 in 2022, then plunged by 57.49% to $71000.0 in 2023, then jumped by 753.52% to $606000.0 in 2024, then plunged by 55.78% to $268000.0 in 2025.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $268000.0 in Q3 2025, $265000.0 in Q2 2025, and $380000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 268,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 380,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 167,000.00 |
| Sep 30, 2022 | 74,000.00 |
| Jun 30, 2022 | 39,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | 26,000.00 |
| Dec 31, 2020 | 25,000.00 |